Alteration in spleen lymphoid populations associated with specific amino acid depletion during (L)-asparaginase treatment

J. A. Distasio, D. L. Durden, R. D. Paul, Mehrdad Nadji

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Treatment with antileukemic asparaginases isolated from Escherichia coli and Erwinia carotovora is accompanied by pronounced toxicity and immunosuppression. The capability of these enzymes to hydrolyze (L)-glutamine and to limit serum levels of this amino acid as well as asparagine has led investigators to hypothesize that glutaminase activity may be responsible for the side effect observed during treatment. We have isolated a glutaminase-free asparaginase with potent antilymphoma activity from Vibrio succinogenes. With the use of this enzyme, we have demonstrated that asparagine depletion alone does not result in suppression of humoral or cell-mediated responses after immunization with sheep red blood cells. In contrast, treatment with E. coli asparaginase abolishes these immune responses. In the present study, we investigated the effects of specific amino acid depletion resulting from asparaginase treatment on spleen histology and lymphocyte populations. Administration by i.p. injection of 50 IU of E. coli asparaginase per day for 4 days resulted in a marked reduction in the size of lymphoid follicles within the spleen concomitant with reduced germinal centers. There appeared to be a significant change in reactivity of the germinal centers, evidenced by a decrease in immunoblasts (B-cells). These findings were confirmed by a sensitive peroxidase-antiperoxidase staining procedure for immunoglobulin-containing cells. Examination of lymphocyte subpopulations within the spleen revealed that there was nearly a 40% decrease in the percentage of Slg-bearing cells accompanied by an increase in the ratio of Thy 1.2-bearing cells. The ratio of Lyt-2 to Lyt-1 cells was unchanged as compared to control animals. The data support the hypothesis that glutamine or glutamine combined with asparagine depletion resulting from the treatment of E. coli asparaginase causes a marked decrease in spleen lymphocytes of the B-cell lineage. In contrast, asparagine deprivation alone, caused by the administration of the glutaminase-free asparaginase from V. succinogenes, does not affect spleen histology or lymphocyte marker distribution. Thus, the asparaginase from V. succinogenes should serve as an effective antileukemic agent without causing deleterious effects on the immune system.

Original languageEnglish
Pages (from-to)252-258
Number of pages7
JournalCancer Research
Volume42
Issue number1
StatePublished - Jan 1 1982

Fingerprint

Asparaginase
Spleen
Asparagine
Amino Acids
Glutamine
Population
Escherichia coli
Germinal Center
Lymphocytes
Histology
B-Lymphocytes
Therapeutics
Pectobacterium carotovorum
Glutaminase
Vibrio
Lymphocyte Subsets
Cell Lineage
Enzymes
Immunosuppression
Peroxidase

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Alteration in spleen lymphoid populations associated with specific amino acid depletion during (L)-asparaginase treatment. / Distasio, J. A.; Durden, D. L.; Paul, R. D.; Nadji, Mehrdad.

In: Cancer Research, Vol. 42, No. 1, 01.01.1982, p. 252-258.

Research output: Contribution to journalArticle

@article{4062ddaa988e43a7ad404784427a6fb4,
title = "Alteration in spleen lymphoid populations associated with specific amino acid depletion during (L)-asparaginase treatment",
abstract = "Treatment with antileukemic asparaginases isolated from Escherichia coli and Erwinia carotovora is accompanied by pronounced toxicity and immunosuppression. The capability of these enzymes to hydrolyze (L)-glutamine and to limit serum levels of this amino acid as well as asparagine has led investigators to hypothesize that glutaminase activity may be responsible for the side effect observed during treatment. We have isolated a glutaminase-free asparaginase with potent antilymphoma activity from Vibrio succinogenes. With the use of this enzyme, we have demonstrated that asparagine depletion alone does not result in suppression of humoral or cell-mediated responses after immunization with sheep red blood cells. In contrast, treatment with E. coli asparaginase abolishes these immune responses. In the present study, we investigated the effects of specific amino acid depletion resulting from asparaginase treatment on spleen histology and lymphocyte populations. Administration by i.p. injection of 50 IU of E. coli asparaginase per day for 4 days resulted in a marked reduction in the size of lymphoid follicles within the spleen concomitant with reduced germinal centers. There appeared to be a significant change in reactivity of the germinal centers, evidenced by a decrease in immunoblasts (B-cells). These findings were confirmed by a sensitive peroxidase-antiperoxidase staining procedure for immunoglobulin-containing cells. Examination of lymphocyte subpopulations within the spleen revealed that there was nearly a 40{\%} decrease in the percentage of Slg-bearing cells accompanied by an increase in the ratio of Thy 1.2-bearing cells. The ratio of Lyt-2 to Lyt-1 cells was unchanged as compared to control animals. The data support the hypothesis that glutamine or glutamine combined with asparagine depletion resulting from the treatment of E. coli asparaginase causes a marked decrease in spleen lymphocytes of the B-cell lineage. In contrast, asparagine deprivation alone, caused by the administration of the glutaminase-free asparaginase from V. succinogenes, does not affect spleen histology or lymphocyte marker distribution. Thus, the asparaginase from V. succinogenes should serve as an effective antileukemic agent without causing deleterious effects on the immune system.",
author = "Distasio, {J. A.} and Durden, {D. L.} and Paul, {R. D.} and Mehrdad Nadji",
year = "1982",
month = "1",
day = "1",
language = "English",
volume = "42",
pages = "252--258",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - Alteration in spleen lymphoid populations associated with specific amino acid depletion during (L)-asparaginase treatment

AU - Distasio, J. A.

AU - Durden, D. L.

AU - Paul, R. D.

AU - Nadji, Mehrdad

PY - 1982/1/1

Y1 - 1982/1/1

N2 - Treatment with antileukemic asparaginases isolated from Escherichia coli and Erwinia carotovora is accompanied by pronounced toxicity and immunosuppression. The capability of these enzymes to hydrolyze (L)-glutamine and to limit serum levels of this amino acid as well as asparagine has led investigators to hypothesize that glutaminase activity may be responsible for the side effect observed during treatment. We have isolated a glutaminase-free asparaginase with potent antilymphoma activity from Vibrio succinogenes. With the use of this enzyme, we have demonstrated that asparagine depletion alone does not result in suppression of humoral or cell-mediated responses after immunization with sheep red blood cells. In contrast, treatment with E. coli asparaginase abolishes these immune responses. In the present study, we investigated the effects of specific amino acid depletion resulting from asparaginase treatment on spleen histology and lymphocyte populations. Administration by i.p. injection of 50 IU of E. coli asparaginase per day for 4 days resulted in a marked reduction in the size of lymphoid follicles within the spleen concomitant with reduced germinal centers. There appeared to be a significant change in reactivity of the germinal centers, evidenced by a decrease in immunoblasts (B-cells). These findings were confirmed by a sensitive peroxidase-antiperoxidase staining procedure for immunoglobulin-containing cells. Examination of lymphocyte subpopulations within the spleen revealed that there was nearly a 40% decrease in the percentage of Slg-bearing cells accompanied by an increase in the ratio of Thy 1.2-bearing cells. The ratio of Lyt-2 to Lyt-1 cells was unchanged as compared to control animals. The data support the hypothesis that glutamine or glutamine combined with asparagine depletion resulting from the treatment of E. coli asparaginase causes a marked decrease in spleen lymphocytes of the B-cell lineage. In contrast, asparagine deprivation alone, caused by the administration of the glutaminase-free asparaginase from V. succinogenes, does not affect spleen histology or lymphocyte marker distribution. Thus, the asparaginase from V. succinogenes should serve as an effective antileukemic agent without causing deleterious effects on the immune system.

AB - Treatment with antileukemic asparaginases isolated from Escherichia coli and Erwinia carotovora is accompanied by pronounced toxicity and immunosuppression. The capability of these enzymes to hydrolyze (L)-glutamine and to limit serum levels of this amino acid as well as asparagine has led investigators to hypothesize that glutaminase activity may be responsible for the side effect observed during treatment. We have isolated a glutaminase-free asparaginase with potent antilymphoma activity from Vibrio succinogenes. With the use of this enzyme, we have demonstrated that asparagine depletion alone does not result in suppression of humoral or cell-mediated responses after immunization with sheep red blood cells. In contrast, treatment with E. coli asparaginase abolishes these immune responses. In the present study, we investigated the effects of specific amino acid depletion resulting from asparaginase treatment on spleen histology and lymphocyte populations. Administration by i.p. injection of 50 IU of E. coli asparaginase per day for 4 days resulted in a marked reduction in the size of lymphoid follicles within the spleen concomitant with reduced germinal centers. There appeared to be a significant change in reactivity of the germinal centers, evidenced by a decrease in immunoblasts (B-cells). These findings were confirmed by a sensitive peroxidase-antiperoxidase staining procedure for immunoglobulin-containing cells. Examination of lymphocyte subpopulations within the spleen revealed that there was nearly a 40% decrease in the percentage of Slg-bearing cells accompanied by an increase in the ratio of Thy 1.2-bearing cells. The ratio of Lyt-2 to Lyt-1 cells was unchanged as compared to control animals. The data support the hypothesis that glutamine or glutamine combined with asparagine depletion resulting from the treatment of E. coli asparaginase causes a marked decrease in spleen lymphocytes of the B-cell lineage. In contrast, asparagine deprivation alone, caused by the administration of the glutaminase-free asparaginase from V. succinogenes, does not affect spleen histology or lymphocyte marker distribution. Thus, the asparaginase from V. succinogenes should serve as an effective antileukemic agent without causing deleterious effects on the immune system.

UR - http://www.scopus.com/inward/record.url?scp=0020086140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020086140&partnerID=8YFLogxK

M3 - Article

VL - 42

SP - 252

EP - 258

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 1

ER -